Literature DB >> 25728630

Pitt-Hopkins Mouse Model has Altered Particular Gastrointestinal Transits In Vivo.

Vladimir Grubišić1, Andrew J Kennedy1, J David Sweatt1, Vladimir Parpura1,2.   

Abstract

Pitt-Hopkins syndrome (PTHS) is a neurodevelopmental disorder, classified as an autism spectrum disorder that is caused by the haploinsufficiency of Transcription Factor 4 (TCF4). The most common non-neurological symptoms in PTHS patients are gastrointestinal (GI) disturbances, mainly gastroesophageal reflux and severe constipation (in about 30 and 75% of PTHS patients, respectively). We hypothesized that the recently recognized mouse model of PTHS will exhibit problems with their gut function. We conducted series of in vivo tests on 15- to 19- week old male mice, heterozygous for the TCF4 functional deletion, mimicking the TCF4 haploinsufficiency in PTHS patients, and their wild type littermates. Data collection and initial analysis were performed blindly, that is, the genotyping key was received after the mean values were calculated for each individual animal, and then mean/median of each group was subsequently calculated. Body weight, fecal pellet output, and fluid content were similar between the groups, indicating normal gross growth of PTHS mice and their overall physiological GI motility and intestinal secretion/absorption. There were no significant differences in gut length and gross appearance pointing out that PTHS mice have normal gut in gross anatomical terms. However, the assessment of gut transit indicates that, while whole-gut transit velocity was similar between the groups, the upper GI and distal colon transit velocities were significantly reduced in the PTHS mice. This is the first evidence of specific gut related problems in the PTHS mice. Our study also validates the TCF4 functional knockout mice as an animal model to study PTHS-associated GI disturbances.
© 2015 International Society for Autism Research, Wiley Periodicals, Inc.

Entities:  

Keywords:  E2-2; ITF2; PTHS mouse model; TCF4; gut transit

Mesh:

Year:  2015        PMID: 25728630      PMCID: PMC5724775          DOI: 10.1002/aur.1467

Source DB:  PubMed          Journal:  Autism Res        ISSN: 1939-3806            Impact factor:   5.216


  21 in total

Review 1.  Transcriptional control of dendritic cell development.

Authors:  Kenneth M Murphy
Journal:  Adv Immunol       Date:  2013       Impact factor: 3.543

2.  Effect of adrenergic and nitrergic blockade on experimental ileus in rats.

Authors:  B Y De Winter; G E Boeckxstaens; J G De Man; T G Moreels; A G Herman; P A Pelckmans
Journal:  Br J Pharmacol       Date:  1997-02       Impact factor: 8.739

Review 3.  The enteric nervous system.

Authors:  R K Goyal; I Hirano
Journal:  N Engl J Med       Date:  1996-04-25       Impact factor: 91.245

4.  Mutations in TCF4, encoding a class I basic helix-loop-helix transcription factor, are responsible for Pitt-Hopkins syndrome, a severe epileptic encephalopathy associated with autonomic dysfunction.

Authors:  Jeanne Amiel; Marlene Rio; Loic de Pontual; Richard Redon; Valerie Malan; Nathalie Boddaert; Perrine Plouin; Nigel P Carter; Stanislas Lyonnet; Arnold Munnich; Laurence Colleaux
Journal:  Am J Hum Genet       Date:  2007-03-23       Impact factor: 11.025

5.  Haploinsufficiency of TCF4 causes syndromal mental retardation with intermittent hyperventilation (Pitt-Hopkins syndrome).

Authors:  Christiane Zweier; Maarit M Peippo; Juliane Hoyer; Sergio Sousa; Armand Bottani; Jill Clayton-Smith; William Reardon; Jorge Saraiva; Alexandra Cabral; Ina Gohring; Koen Devriendt; Thomy de Ravel; Emilia K Bijlsma; Raoul C M Hennekam; Alfredo Orrico; Monika Cohen; Alexander Dreweke; Andre Reis; Peter Nurnberg; Anita Rauch
Journal:  Am J Hum Genet       Date:  2007-03-23       Impact factor: 11.025

Review 6.  Interplay between inflammation, immune system and neuronal pathways: effect on gastrointestinal motility.

Authors:  Benedicte-Y De Winter; Joris-G De Man
Journal:  World J Gastroenterol       Date:  2010-11-28       Impact factor: 5.742

7.  Ca2+ responses in enteric glia are mediated by connexin-43 hemichannels and modulate colonic transit in mice.

Authors:  Jonathon McClain; Vladimir Grubišić; David Fried; Roberto A Gomez-Suarez; Gina M Leinninger; Jean Sévigny; Vladimir Parpura; Brian D Gulbransen
Journal:  Gastroenterology       Date:  2013-11-06       Impact factor: 22.682

8.  B-lymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes, E2A, E2-2, and HEB.

Authors:  Y Zhuang; P Cheng; H Weintraub
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

9.  Knockdown of human TCF4 affects multiple signaling pathways involved in cell survival, epithelial to mesenchymal transition and neuronal differentiation.

Authors:  Marc P Forrest; Adrian J Waite; Enca Martin-Rendon; Derek J Blake
Journal:  PLoS One       Date:  2013-08-23       Impact factor: 3.240

Review 10.  Pitt-Hopkins Syndrome: intellectual disability due to loss of TCF4-regulated gene transcription.

Authors:  J David Sweatt
Journal:  Exp Mol Med       Date:  2013-05-03       Impact factor: 8.718

View more
  16 in total

Review 1.  The bowel and beyond: the enteric nervous system in neurological disorders.

Authors:  Meenakshi Rao; Michael D Gershon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-07-20       Impact factor: 46.802

Review 2.  Pitt-Hopkins Syndrome: A Review of Current Literature, Clinical Approach, and 23-Patient Case Series.

Authors:  Kimberly Goodspeed; Cassandra Newsom; Mary Ann Morris; Craig Powell; Patricia Evans; Sailaja Golla
Journal:  J Child Neurol       Date:  2018-01-10       Impact factor: 1.987

3.  Common Pathophysiology in Multiple Mouse Models of Pitt-Hopkins Syndrome.

Authors:  Courtney Thaxton; Alexander D Kloth; Ellen P Clark; Sheryl S Moy; Raymond A Chitwood; Benjamin D Philpot
Journal:  J Neurosci       Date:  2017-12-08       Impact factor: 6.167

4.  WNT/β-Catenin Pathway and Epigenetic Mechanisms Regulate the Pitt-Hopkins Syndrome and Schizophrenia Risk Gene TCF4.

Authors:  Krista M Hennig; Daniel M Fass; Wen-Ning Zhao; Steven D Sheridan; Ting Fu; Serkan Erdin; Alexei Stortchevoi; Diane Lucente; Jannine D Cody; David Sweetser; James F Gusella; Michael E Talkowski; Stephen J Haggarty
Journal:  Mol Neuropsychiatry       Date:  2017-07-14

5.  Two modes of enteric gliotransmission differentially affect gut physiology.

Authors:  Vladimir Grubišić; Vladimir Parpura
Journal:  Glia       Date:  2017-02-07       Impact factor: 7.452

6.  Tcf4 Regulates Synaptic Plasticity, DNA Methylation, and Memory Function.

Authors:  Andrew J Kennedy; Elizabeth J Rahn; Brynna S Paulukaitis; Katherine E Savell; Holly B Kordasiewicz; Jing Wang; John W Lewis; Jessica Posey; Sarah K Strange; Mikael C Guzman-Karlsson; Scott E Phillips; Kyle Decker; S Timothy Motley; Eric E Swayze; David J Ecker; Todd P Michael; Jeremy J Day; J David Sweatt
Journal:  Cell Rep       Date:  2016-08-25       Impact factor: 9.423

7.  Psychiatric Risk Gene Transcription Factor 4 Regulates Intrinsic Excitability of Prefrontal Neurons via Repression of SCN10a and KCNQ1.

Authors:  Matthew D Rannals; Gregory R Hamersky; Stephanie Cerceo Page; Morganne N Campbell; Aaron Briley; Ryan A Gallo; BaDoi N Phan; Thomas M Hyde; Joel E Kleinman; Joo Heon Shin; Andrew E Jaffe; Daniel R Weinberger; Brady J Maher
Journal:  Neuron       Date:  2016-03-10       Impact factor: 17.173

8.  Molecular Mechanisms of Transcription Factor 4 in Pitt Hopkins Syndrome.

Authors:  Matthew D Rannals; Brady J Maher
Journal:  Curr Genet Med Rep       Date:  2017-02-11

9.  Effects of 'Healthy' Fecal Microbiota Transplantation against the Deterioration of Depression in Fawn-Hooded Rats.

Authors:  Bing Hu; Promi Das; Xianglin Lv; Meng Shi; Jiye Aa; Kun Wang; Liping Duan; Jack A Gilbert; Yong Nie; Xiao-Lei Wu
Journal:  mSystems       Date:  2022-04-28       Impact factor: 7.324

10.  The second brain in autism spectrum disorder: could connexin 43 expressed in enteric glial cells play a role?

Authors:  Vladimir Grubišić; Vladimir Parpura
Journal:  Front Cell Neurosci       Date:  2015-07-03       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.